T von Rüden

1.5k total citations
15 papers, 1.3k citations indexed

About

T von Rüden is a scholar working on Molecular Biology, Radiology, Nuclear Medicine and Imaging and Oncology. According to data from OpenAlex, T von Rüden has authored 15 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 6 papers in Radiology, Nuclear Medicine and Imaging and 5 papers in Oncology. Recurrent topics in T von Rüden's work include Monoclonal and Polyclonal Antibodies Research (6 papers), Virus-based gene therapy research (4 papers) and Glycosylation and Glycoproteins Research (3 papers). T von Rüden is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (6 papers), Virus-based gene therapy research (4 papers) and Glycosylation and Glycoproteins Research (3 papers). T von Rüden collaborates with scholars based in Austria, Germany and United States. T von Rüden's co-authors include Erwin F. Wagner, Eli Gilboa, Philip W. Kantoff, Titus Kretzschmar, W. French Anderson, Donna Armentano, Miri Seiberg, W.F. Anderson, Ulrich Rüther and Rebecca Haffner and has published in prestigious journals such as Proceedings of the National Academy of Sciences, The EMBO Journal and Blood.

In The Last Decade

T von Rüden

15 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
T von Rüden Austria	11	946	607	344	174	143	15	1.3k
Leah Lipsich United States	15	1.1k 1.2×	512 0.8×	391 1.1×	195 1.1×	178 1.2×	19	1.6k
R A Bosselman United States	15	826 0.9×	691 1.1×	217 0.6×	405 2.3×	90 0.6×	26	1.6k
Dina Markowitz United States	9	1.3k 1.4×	1.0k 1.7×	447 1.3×	435 2.5×	66 0.5×	12	2.0k
Natalie A. Lissy United States	7	1.3k 1.3×	329 0.5×	397 1.2×	298 1.7×	38 0.3×	9	1.6k
Nanette Mittereder United States	10	905 1.0×	669 1.1×	323 0.9×	437 2.5×	64 0.4×	11	1.6k
Gaby Brouns Netherlands	13	851 0.9×	671 1.1×	346 1.0×	555 3.2×	105 0.7×	17	1.5k
Y K Fung United States	17	834 0.9×	288 0.5×	536 1.6×	148 0.9×	41 0.3×	22	1.3k
Melinda VanRoey United States	18	707 0.7×	412 0.7×	768 2.2×	552 3.2×	107 0.7×	21	1.4k
H L Ozer United States	22	897 0.9×	364 0.6×	729 2.1×	150 0.9×	82 0.6×	39	1.6k
C. Lagrou France	14	893 0.9×	331 0.5×	170 0.5×	291 1.7×	81 0.6×	19	1.3k

Countries citing papers authored by T von Rüden

Since Specialization

Citations

This map shows the geographic impact of T von Rüden's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by T von Rüden with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites T von Rüden more than expected).

Fields of papers citing papers by T von Rüden

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by T von Rüden. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by T von Rüden. The network helps show where T von Rüden may publish in the future.

Co-authorship network of co-authors of T von Rüden

This figure shows the co-authorship network connecting the top 25 collaborators of T von Rüden. A scholar is included among the top collaborators of T von Rüden based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with T von Rüden. T von Rüden is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

1.

Frisch, Christian, Bodo Brocks, Ralf Ostendorp, et al.. (2003). From EST to IHC: human antibody pipeline for target research. Journal of Immunological Methods. 275(1-2). 203–212. 15 indexed citations

2.

Kretzschmar, Titus & T von Rüden. (2002). Antibody discovery: phage display. Current Opinion in Biotechnology. 13(6). 598–602. 98 indexed citations

3.

Rüden, T von, et al.. (1995). Generation of high-titer retroviral vectors following receptor-mediated, adenovirus-augmented transfection.. PubMed. 18(3). 484–9. 8 indexed citations

4.

Okada, Seiji, Zhao‐Qi Wang, Agamemnon E. Grigoriadis, Erwin F. Wagner, & T von Rüden. (1994). Mice lacking c-fos have normal hematopoietic stem cells but exhibit altered B-cell differentiation due to an impaired bone marrow environment. Molecular and Cellular Biology. 14(1). 382–390. 47 indexed citations

5.

Gottlieb, Eyal, Rebecca Haffner, T von Rüden, Erwin F. Wagner, & Moshe Oren. (1994). Down-regulation of wild-type p53 activity interferes with apoptosis of IL-3-dependent hematopoietic cells following IL-3 withdrawal.. The EMBO Journal. 13(6). 1368–1374. 146 indexed citations

6.

Rüden, T von, Laura Stingl, Axel Ullrich, & Erwin F. Wagner. (1993). Rescue of W-associated mast cell defects in W/Wv bone marrow cells by ectopic expression of normal and mutant epidermal growth factor receptors. Blood. 82(5). 1463–1470. 3 indexed citations

7.

Redemann, Norbert, Bernhard Holzmann, T von Rüden, et al.. (1992). Anti-oncogenic activity of signalling-defective epidermal growth factor receptor mutants.. Molecular and Cellular Biology. 12(2). 491–498. 110 indexed citations

8.

Bourette, Roland P., et al.. (1992). Insulin-Like Growth Factor-1 Stimulates Proliferation of Myeloid FDC-P1 Cells Overexpressing the Human Colony-Stimulating Factor-1 Receptor. Growth Factors. 7(4). 315–325. 3 indexed citations

9.

Rüden, T von, et al.. (1992). Development of a lethal mast cell disease in mice reconstituted with bone marrow cells expressing the v-erbB oncogene. Blood. 79(12). 3145–3158. 13 indexed citations

10.

Rüden, T von, et al.. (1992). Development of a lethal mast cell disease in mice reconstituted with bone marrow cells expressing the v-erbB oncogene. Blood. 79(12). 3145–3158. 10 indexed citations

11.

Redemann, Norbert, Bernhard Holzmann, T von Rüden, et al.. (1992). Anti-Oncogenic Activity of Signalling-Defective Epidermal Growth Factor Receptor Mutants. Molecular and Cellular Biology. 12(2). 491–498. 9 indexed citations

12.

Rüden, T von & Eli Gilboa. (1989). Inhibition of human T-cell leukemia virus type I replication in primary human T cells that express antisense RNA. Journal of Virology. 63(2). 677–682. 39 indexed citations

13.

Rüden, T von & Erwin F. Wagner. (1988). Expression of functional human EGF receptor on murine bone marrow cells.. The EMBO Journal. 7(9). 2749–2756. 52 indexed citations

14.

Armentano, Donna, et al.. (1987). Effect of internal viral sequences on the utility of retroviral vectors. Journal of Virology. 61(5). 1647–1650. 310 indexed citations

15.

Rüden, T von, Philip W. Kantoff, Miri Seiberg, et al.. (1986). Self-inactivating retroviral vectors designed for transfer of whole genes into mammalian cells.. Proceedings of the National Academy of Sciences. 83(10). 3194–3198. 409 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact